Back to mobile site

TD Cowen Boston Scientific (BSX): 'We Maintain Our Constructive 2027-Based View'

September 17, 2026 9:39 AM EDT Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $56.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login